Outpatient reduced-intensity allogeneic stem cell transplantation for patients with refractory or relapsed lymphomas compared with autologous stem cell transplantation using a simplified method

Annals of Hematology

Volumn 89, Issue 10, 2010, Pages 1045-1052

  Gutiérrez Aguirre, Cesar Homero ^a   Ruiz Argüelles, Guillermo ^b   Cantú Rodríguez, Olga Graciela ^a   González Llano, Oscar ^a   Jaime Pérez, José Carlos ^a   García Rodríguez, Fernando ^a   López Otero, Avril ^b   Herrera Garza, José Luis ^a   Gómez Almaguer, David ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

Author keywords

Allo RIC; Bone marrow transplant; Fludarabine; Hodgkin's lymphoma; Non Hodgkin's lymphoma; Stem cells

Indexed keywords

ACICLOVIR; BLEOMYCIN; BUSULFAN; CARMUSTINE; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; FLUDARABINE; METHOTREXATE; ONDANSETRON; PREDNISONE; PROCARBAZINE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ADVANCED CANCER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANGIOCENTRIC LYMPHOMA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BURKITT LYMPHOMA; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CARDIOTOXICITY; CAUSE OF DEATH; CD34 SELECTION; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG BLOOD LEVEL; DRUG DOSE SEQUENCE; FEMALE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; IMMUNOBLASTIC LYMPHOMA; INCIDENCE; LARGE CELL LYMPHOMA; LOW DRUG DOSE; LUNG TOXICITY; LYMPHOBLASTOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MIXED CELLULARITY HODGKIN LYMPHOMA; MULTIPLE CYCLE TREATMENT; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; OUTPATIENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REDUCED INTENSITY CONDITIONING; SEPSIS; SURVIVAL TIME; ALLOTRANSPLANTATION; AMBULATORY CARE; AUTOTRANSPLANTATION; DISEASE COURSE; DISEASE FREE SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; METHODOLOGY; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77956691182     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0986-1     Document Type: Article

References (33)

1. G Bellesi L Rigacci G Longo R Alterini F Bernardi A Messori, et al. 2000 Treatment of large cell lymphoma with the Fi2 regimen (doxorubicin, vincristinem cyclophosphamide, bleomycin and prednisone): 25-year experience Oncol Rep 7 891 896 1:CAS:528:DC%2BD3cXksVCjt7s%3D 10854565
2. SJ Horning J Williams NL Bartlett JM Bennett RT Hoppe D Neuberg, et al. 2000 Assessment of the Stanford V regimen and consolidative radiotherapy for bulky and advanced Hodgkińs disease: Eastern Cooperative Oncology Group pilot study E1492 J Clin Oncol 18 972 980 1:CAS:528:DC%2BD3cXitVCgsLw%3D 10694546
3. V Bonfante A Santoro S Viviani L Devizzi M Balzarotti F Soncini, et al. 1997 Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD J Clin Oncol 15 528 534 1:STN:280:DyaK2s7nvVOnsw%3D%3D 9053474
4. HM Lazarus FR Loberiza Jr ZMJ Armitage BKK JO A Bashey BJ Bolwell, et al. 2001 Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR) Bone Marrow Transplant 27 387 396 10.1038/sj.bmt.1702796 1:STN:280:DC%2BD3MvkslejsA%3D%3D 11313668 (Pubitemid 32201347)
5. G Akpek RF Ambider S Piantadosi RA Abrams RA Brodsky GB Vogelsang, et al. 2001 Long-term results of blood and marrow transplantation for Hodgkin's lymphoma J Clin Oncol 19 4314 4321 1:STN:280:DC%2BD3MnosFWnsg%3D%3D 11731514
6. AP Rapaport R Lifton LS Constine RE Duerst CN Abboud JL Liesveld, et al. 1997 Autotransplantation for relapsed or refractory non-Hodgkińs lymphoma (NHL): long-term follow-up and analysis of prognostic factors Bone Marrow Transplant 19 883 890 10.1038/sj.bmt.1700772
7. I Aksentijevich RJ Jones RF Ambinder E Garrett-Mayer IW Flinn 2006 Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non Hodgkin's lymphoma Biol Blood Marrow Transplant 12 770 777 10.1016/j.bbmt.2006.05.018
8. CH Moskowitz SD Nimer AD Zelenetz T Trippett EE Hedrick DA Filippa, et al. 2001 A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model Blood 97 616 623 10.1182/blood.V97.3.616 1:CAS:528:DC%2BD3MXhtVSjsL8%3D 11157476 (Pubitemid 32113392)
9. NS Majhail DJ Weisdorf TE Defor JS Miller PB McGlave A Slungaard, et al. 2006 Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma Biol Blood Marrow Transplant 12 1065 1072 10.1016/j.bbmt.2006.06.006 17084370
10. RJ Jones RF Ambinder S Piantadosi GW Santos 1991 Evidence of a graft versus lymphoma effect associated with allogeneic bone marrow transplantation Blood 77 649 653 1:STN:280:DyaK3M7itV2ksg%3D%3D 1991174
11. SP Robinson AH Goldstone S Mackinnon A Carella N Russell C Ruiz de Elvira, et al. 2002 Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation Blood 100 4310 4316 10.1182/blood-2001-11-0107 1:CAS:528:DC%2BD38XpsFCqs7w%3D 12393626 (Pubitemid 35429668)
12. M Tomblyn C Brunstein LJ Burns JS Miller M MacMillan TE DeFor, et al. 2008 Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation Biol Blood Marrow Transplant 14 538 545 10.1016/j.bbmt.2008.02. 014 18410896 (Pubitemid 351494746)
13. I Alvarez A Sureda MD Caballero A Urbano-Ispizua JM Ribera M Canales, et al. 2006 Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma: results of a Spanish prospective cooperative protocol Biol Blood Marrow Transplant 12 172 183 10.1016/j.bbmt.2005.09.009 16443515 (Pubitemid 43138012)
14. DL Porter EA Stadtmauer HM Lazarus 2003 GVHD: graft-versus-host-disease or graft-versus-Hodgkin's disease? An old acronym with new meaning Bone Marrow Transplant 31 739 746 10.1038/sj.bmt.1703895 1:STN:280:DC%2BD3s3htFWqsw%3D%3D 12732878
15. JE Anderson MR Litzow FR Appelbaum G Schoch LD Fisher CD Buckner, et al. 1993 Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21 years Seattle experience J Clin Oncol 11 2342 2350 1:STN:280:DyaK2c%2FmsFyltw%3D%3D 8246023
16. A Kessinger JO Armitage JD Landmark 1988 Autologus peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy Blood 71 723 727 1:STN:280:DyaL1c7ltVajtw%3D%3D 2894230
17. D Gómez-Almaguer GJ Ruiz-Argüelles A Ruiz-Argüelles O González-Llano OE Cantú NE Hernández 2000 Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis Bone Marrow Transplant 25 131 133 10.1038/sj.bmt.1702100 10673669
18. GJ Ruiz-Argüelles D Gómez-Almaguer B López- Martínez OG Cantú-Rodríguez JC Jaime-Pérez O González-Llano 2002 Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia Haematologica 87 894 896 12161373
19. A Ruiz-Argüelles 1992 Flow cytometry in the clinical laboratory. Principles, applications and problems Ann Biol Clin 50 735 743
20. GJ Ruiz-Delgado KI Gutierrez-Riverol CH Gutierrez-Aguirre D Gomez-Almaguer R Eyzaguirre-Zapata M Priesca-Marin, et al. 2009 A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting Blood Transfus 7 127 131 19503634
21. Ruiz-Argüelles A, Orfao A (1996) Caracterización y evaluación de células totipotenciales en sangre periférica y médula ósea. In: Ruiz-Argüelles GJ, San-Miguel JF (eds) Actualización en Leucemias. Editorial Médica Panamericana, México City, pp 79-82
22. S Giralt E Estey M Albitar K Van Besien G Rondón P Anderlini, et al. 1997 Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 89 4531 4536 1:CAS:528:DyaK2sXjvFCkt7g%3D 9192777
23. PY Yam LD Petz RG Knowlton RB Wallace AD Stock G de Lange, et al. 1987 Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation Transplantation 43 399 407 10.1097/00007890-198703000-00016 1:CAS:528:DyaL2sXktlOnurc%3D 2881382
24. PP Carbone HS Kaplan K Musshogg DW Smithers M Tubiana 1971 Report of the Committee on Hodgkin's Disease Staging Classification Cancer Res 31 1860 1861 1:STN:280:DyaE38%2Fks1yitw%3D%3D 5121694
25. HM Shulman KM Sullivan PL Weiden 1980 Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients Am J Med 69 204 217 10.1016/0002-9343(80)90380-0 1:STN:280:DyaL3c3mtlSksg%3D%3D 6996481 (Pubitemid 10036817)
26. CH Gutierrez-Aguirre OG Cantú-Rodríguez O Gonzalez-Llano R Salazar-Riojas O Martinez-González JC Jaime-Pérez, et al. 2007 Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience Hematology 12 3 193 197 10.1080/10245330701214285 1:CAS:528:DC%2BD2sXmt1ansrs%3D 17558694 (Pubitemid 46930245)
27. B-M Svahn B Bjurman KE Myrback J Aschan O Rindgen 2000 Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial Bone Marrow Transplant 26 1057 1060 10.1038/sj.bmt.1702672 1:STN:280:DC%2BD3Mzgtlyjuw%3D%3D 11108303
28. PA McSweeney D Niederwiser JA Shizuru BM Sandmaier AJ Molina DG Maloney, et al. 2001 Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Blood 97 3390 3400 10.1182/blood.V97.11.3390 1:CAS:528:DC%2BD3MXktFOkt7c%3D 11369628
29. CH Gutierrez-Aguirre D Gomez-Almaguer OG Cantu-Rodríguez O Gonzalez-Llano JC Jaime-Perez S Herena-Perez CA Manzano, et al. 2007 Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study Bone Marrow Transplant 40 6 535 539 10.1038/sj.bmt.1705769 1:CAS:528:DC%2BD2sXpvFWkt7k%3D 17618317 (Pubitemid 47382123)
30. OG Cantú-Rodríguez JC Jaime-Perez CH Gutierrez-Aguirre O González-Llano C Mancias-Guerra LC Tarin-Arzaga, et al. 2007 Outpatient allografting using non-myeloablative conditioning: the Mexican experience Bone Marrow Transplant 40 2 119 123 10.1038/sj.bmt.1705700 17530008 (Pubitemid 47046209)
31. H Bertz G Illerhaus H Veelken J Finke 2002 Allogeneic hematopoietic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens Ann Oncol 13 135 139 10.1093/annonc/mdf010 1:STN:280:DC%2BD387islymsw%3D%3D 11863095 (Pubitemid 34436737)
32. PD Kottaridis DW Milligan R Chopra RK Chakraverty S Chakrabarti S Robinson, et al. 2000 In vivo CAMPATH-1H prevents graft-versus host disease following nonmyeloablative stem cell transplantation Blood 96 2419 2425 1:CAS:528:DC%2BD3cXntVarurc%3D 11001893
33. D Gómez-Almaguer GJ Ruiz-Argüelles O González-Llano O González-Llano H Gutiérrez-Aguirre O Cantú- Rodríguez, et al. 2008 Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease Biol Blood Marrow Transplant 14 1 10 15 10.1016/j.bbmt.2007.08.052 18158956 (Pubitemid 350286746)